During the past decade, Wisconsin Clinical Cancer Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Wisconsin Clinical Cancer Center" are "AL Amyloidosis" (1 trials), "Adult Solid Neoplasm" (1 trials), "Iris Melanoma" (1 trials), "Medium/Large Size Posterior Uveal Melanoma" (1 trials) and "Multiple Myeloma Progression" (1 trials). Many other conditions were trialed in "Wisconsin Clinical Cancer Center" in a lesser frequency.

Most popular intervention types in "Wisconsin Clinical Cancer Center" are "Drug" (6 trials), "Other" (4 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (2 trials), "NEOD001" (2 trials), "Placebo" (2 trials), "Autologous Stem Cell Transplant (ASCT)" (1 trials) and "Dacarbazine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wisconsin Clinical Cancer Center" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Wisconsin Clinical Cancer Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Wisconsin Clinical Cancer Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Wisconsin Clinical Cancer Center, 3 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".